Waters (WAT) boosts MS offerings with the launch of Xevo MRT, strengthening its Waters operating segment's portfolio.
BD's (BDX) robust product portfolio raises optimism about the stock.
Investors are optimistic about DaVita's (DVA) strength in kidney care.